DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide - PubMed (original) (raw)
DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide
M A Sherman et al. Immunity. 1995 Aug.
Free article
Abstract
Major histocompatibility complex (MHC) class II molecules bind antigenic peptides rapidly after biosynthesis in antigen-presenting cells (APCs). By contrast, the rate of peptide binding to purified class II molecules is remarkably slow. We find that purified HLA-DR molecules bind peptides rapidly in the presence but not the absence of HLA-DM, a recently identified heterodimer required for efficient antigen processing. The same effect is seen with immunoprecipitated DM, suggesting that DM interacts directly with DR. Class II-associated invariant chain peptides (CLIP) are selectively and rapidly released from DR during incubation with DM at pH 5. We conclude that DM is a cofactor that enhances peptide binding to DR molecules through a mechanism involving peptide exchange.
Similar articles
- Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM.
Weber DA, Evavold BD, Jensen PE. Weber DA, et al. Science. 1996 Oct 25;274(5287):618-20. doi: 10.1126/science.274.5287.618. Science. 1996. PMID: 8849454 - Editing of the HLA-DR-peptide repertoire by HLA-DM.
Kropshofer H, Vogt AB, Moldenhauer G, Hammer J, Blum JS, Hämmerling GJ. Kropshofer H, et al. EMBO J. 1996 Nov 15;15(22):6144-54. EMBO J. 1996. PMID: 8947036 Free PMC article. - Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R, Rinderknecht CH, Roh S, Lee AW, Harding JJ, Burster T, Hornell TM, Mellins ED. Busch R, et al. Immunol Rev. 2005 Oct;207:242-60. doi: 10.1111/j.0105-2896.2005.00306.x. Immunol Rev. 2005. PMID: 16181341 Review. - HLA-DM and the MHC class II antigen presentation pathway.
Jensen PE, Weber DA, Thayer WP, Chen X, Dao CT. Jensen PE, et al. Immunol Res. 1999;20(3):195-205. doi: 10.1007/BF02790403. Immunol Res. 1999. PMID: 10741860 Review.
Cited by
- Loading dynamics of one SARS-CoV-2-derived peptide into MHC-II revealed by kinetic models.
Song K, Xu H, Da LT. Song K, et al. Biophys J. 2023 May 2;122(9):1665-1677. doi: 10.1016/j.bpj.2023.03.032. Epub 2023 Mar 24. Biophys J. 2023. PMID: 36964657 Free PMC article. - Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium.
Gopalakrishnan S, Hansen MD, Skovdahl HK, Roseth IA, van Beelen Granlund A, Østvik AE, Bakke I, Sandvik AK, Bruland T. Gopalakrishnan S, et al. Front Immunol. 2022 May 17;13:882277. doi: 10.3389/fimmu.2022.882277. eCollection 2022. Front Immunol. 2022. PMID: 35655783 Free PMC article. - Peculiarities of the Presentation of the Encephalitogenic MBP Peptide by HLA-DR Complexes Providing Protection and Predisposition to Multiple Sclerosis.
Mamedov AE, Filimonova IN, Smirnov IV, Belogurov AA. Mamedov AE, et al. Acta Naturae. 2021 Jan-Mar;13(1):127-133. doi: 10.32607/actanaturae.11008. Acta Naturae. 2021. PMID: 33959392 Free PMC article. - Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.
Szeto C, Bloom JI, Sloane H, Lobos CA, Fodor J, Jayasinghe D, Chatzileontiadou DSM, Grant EJ, Buckle AM, Gras S. Szeto C, et al. Int J Mol Sci. 2020 Sep 25;21(19):7081. doi: 10.3390/ijms21197081. Int J Mol Sci. 2020. PMID: 32992915 Free PMC article. - Why do intestinal epithelial cells express MHC class II?
Heuberger C, Pott J, Maloy KJ. Heuberger C, et al. Immunology. 2021 Apr;162(4):357-367. doi: 10.1111/imm.13270. Epub 2020 Oct 12. Immunology. 2021. PMID: 32966619 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous